FDA approves GSK’s Wellcovorin for cerebral folate deficiency

FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.

No Broad Autism Approval for Leucovorin, Despite FDA Commissioner’s Prior Suggestions

The Food and Drug Administration on March 10 changed the approval for a version of the prescription drug leucovorin to include people with a very rare genetic condition. FDA Commissioner Dr. Marty ...

Hawley introduces bill to strip FDA approval from 'inherently dangerous' abortion pill

Sen. Josh Hawley, R-Mo., introduced a bill to ban the abortion pill mifepristone, calling it "inherently dangerous" and ...

GSK gets US FDA approval for expanded use of RSV vaccine

March 13 (Reuters) - British drugmaker GSK said on Friday the U.S. Food and Drug Administration has expanded the approved age ...
Healio

FDA approves Cosentyx for teens 12 and older with hidradenitis suppurativa

The FDA approved secukimumab for children aged 12 years and older with moderate to severe hidradenitis suppurativa, Novartis announced in a press release.The approval makes secukinumab (Cosentyx) the ...

The first FDA‑approved oral GLP‑1 for weight loss is here

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...
GlobalData on MSN

BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment

The FDA granted the approval following findings from the pivotal POETYK PsA-I and POETYK PsA-II Phase III studies.